The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Nepafenac

Australian Public Assessment Report

AusPAR

AusPAR: Nepafenac [PDF, 806.53 KB]

AusPAR: Nepafenac [Word, 740.31 KB]

Attachment: Product Information: Nepafenac [PDF, 164 KB]

Attachment: Product Information: Nepafenac [Word, 130.5 KB]

Attachment: Extract from Clinical Evaluation Report Nepafenac [PDF, 1.82 MB]

Attachment: Extract from Clinical Evaluation Report Nepafenac [Word, 2.14 MB]

Device/Product Name

Ilevro

Active ingredients

Nepafenac

AusPAR Date

23 December 2015

Published

24 December 2015

Submission Number

PM-2014-03164-1-1

Submission Type

New chemical entity

Decision

Approved